|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/435 | |
| A61K 38/16 | |||
| A61P 35/00 |
| (11) | Number of the document | 1976529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07762831.1 |
| Date of filing the European patent application | 2007-01-19 | |
| (97) | Date of publication of the European application | 2008-10-08 |
| (45) | Date of publication and mention of the grant of the patent | 2013-12-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/001365 |
| Date | 2007-01-19 |
| (87) | Number | WO 2007/089445 |
| Date | 2007-08-09 |
| (30) | Number | Date | Country code |
| 762493 P | 2006-01-27 | US |
| (72) |
OLINER, Jonathan, US
KENDALL, Richard, US
KUMAR, Rakesh, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive M/S 28-2-C, Thousand Oaks, CA 91320-1799,
US
|
| (54) | ANG2 AND VEGF INHIBITOR COMBINATIONS |
| ANG2 AND VEGF INHIBITOR COMBINATIONS |